These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36400597)

  • 1. Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Winnett C; Lu G; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2023 Jan; 119(1):116-126. PubMed ID: 36400597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
    Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
    Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndrome.
    Fisch SC; Nikou AF; Wright EA; Phan JD; Leung KL; Grogan TR; Abbott DH; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Dec; 110(7):1367-1376. PubMed ID: 30503136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Akopians AL; Madrigal VK; Ramirez E; Margolis DJ; Sarma MK; Thomas AM; Grogan TR; Haykal R; Schooler TA; Okeya BL; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4178-4188. PubMed ID: 27571186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Phan JD; Leung KL; Grogan TR; Ding X; Li X; Hoyos LR; Abbott DH; Chazenbalk GD
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2171-2183. PubMed ID: 30649347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
    Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women.
    Dumesic DA; Tulberg A; McNamara M; Grogan TR; Abbott DH; Naik R; Lu G; Chazenbalk GD
    J Endocr Soc; 2021 Nov; 5(11):bvab158. PubMed ID: 34661039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.
    Leung KL; Sanchita S; Pham CT; Davis BA; Okhovat M; Ding X; Dumesic P; Grogan TR; Williams KJ; Morselli M; Ma F; Carbone L; Li X; Pellegrini M; Dumesic DA; Chazenbalk GD
    Clin Epigenetics; 2020 Nov; 12(1):181. PubMed ID: 33228780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome.
    Dumesic DA; Turcu AF; Liu H; Grogan TR; Abbott DH; Lu G; Dharanipragada D; Chazenbalk GD
    J Endocr Soc; 2023 Jul; 7(8):bvad079. PubMed ID: 37404244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism.
    Paoletti AM; Cagnacci A; Orrù M; Ajossa S; Guerriero S; Melis GB
    Fertil Steril; 1999 Sep; 72(3):448-53. PubMed ID: 10519615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
    Gambineri A; Patton L; Vaccina A; Cacciari M; Morselli-Labate AM; Cavazza C; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3970-80. PubMed ID: 16868063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
    Diamanti-Kandarakis E; Mitrakou A; Raptis S; Tolis G; Duleba AJ
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2699-705. PubMed ID: 9709934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.
    Sahin I; Serter R; Karakurt F; Demirbas B; Culha C; Taskapan C; Kosar F; Aral Y
    Gynecol Endocrinol; 2004 Sep; 19(3):115-24. PubMed ID: 15697072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.
    Guedikian AA; Lee AY; Grogan TR; Abbott DH; Largaespada K; Chazenbalk GD; Dumesic DA
    Fertil Steril; 2018 Mar; 109(3):508-515. PubMed ID: 29428312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.